Press Releases Filter Options Archive DateYear20262025202420232022202120202019201820172016201520142013201220112010200920082007MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember View 12 View 12View 24View 48 Categories CorporateFinancialPrescription MedicinesResearch and PipelineSocial ResponsibilityVaccines Keywords All Keywords Covid-19FinanceInvestmentsLeadershipMedicinesPartnershipsResearchResponsibilityVaccines May 2022 05.23.2022 Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third DoseVaccinesCovid-19Vaccines 05.17.2022 Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of AgeVaccinesCovid-19Vaccines 05.13.2022 Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European CommissionVaccinesCovid-19Vaccines March 2022 03.09.2022 Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric ParticipantsVaccinesCovid-19 Page 1 Page 2 Page 3 Page 4 Current page 5
